* Nephros Inc NEPH.OQ NEPH.O is expected to show a rise
in
quarterly revenue when it reports results on February 23.
* The South Orange New Jersey-based company is expected to
report
a 22.0% increase in revenue to $2.848 million from $2.33
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Nephros Inc is for
a loss
of 11 cents per share. For the same quarter last year, the
company reported a loss of 8 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Nephros Inc
is
$13, about 65.2% above its last closing price of $4.52.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 -0.10 -0.10 -0.12 Missed -14.3
Jun. 30 2021 -0.11 -0.11 -0.12 Missed -5.9
Mar. 31 2021 -0.12 -0.12 -0.11 Beat 7.6
Dec. 31 2020 -0.12 -0.11 -0.08 Beat 27.3
Sep. -0.14 -0.14 -0.12 Beat 12.2
30 2020
Jun. 30 2020 -0.15 -0.15 -0.19 Missed -26.7
Mar. 31 2020 -0.08 -0.08 -0.13 Missed -62.5
Dec. 31 2019 -0.11 -0.11 -0.02 Beat 82.4
This summary was machine generated February 22 at 03:01 GMT.
All figures in US dollars unless otherwise stated